• Home
  • Pregnancy &
  • Bookshop
  • Contact us
  • Donate now
  • Frequently Asked Questions
  • Please read

Current Studies at Motherisk: Lamisil in Pregnancy

Motherisk is currently conducting a study to determine the safety of Lamisil (terbinafine) use in pregnancy. This is prescribed for the treatment of fungal infections of the toenail, fingernail and various skin infections. The primary objective of this study is to evaluate the risk for major malformations and other adverse fetal effects following exposure to this medication.

If you are currently pregnant and exposed to Lamisil at any point during the pregnancy, please contact Moumita Sarkar at 1-800-670-6126 or by e-mail. Your participation will involve a follow-up by telephone interview at 6 months after delivery. All calls are strictly confidential.

Valid XHTML 1.0 Transitional [Valid RSS]

* - "MOTHERISK - Treating the mother - Protecting the unborn" is an official mark of The Hospital for Sick Children. All rights reserved.

The information on this website is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and before you take any medications.

Copyright © 1999-2015 The Hospital for Sick Children (SickKids). All rights reserved.

The Hospital for Sick Children (SickKids) is a health-care, teaching and research centre dedicated exclusively to children; affiliated with the University of Toronto. For general inquires please call: 416-813-1500.

  |  Contact SickKids  |  Terms of Use